About Trial Library
Trial Library is building the infrastructure that connects patients to clinical trials as a standard part of care delivery. The company operates an AI-native platform that integrates clinical trials into routine healthcare by activating providers, identifying eligible patients, and supporting them through the complete trial lifecycle. Founded by physician-scientist Dr. Hala Borno, Trial Library addresses a critical gap in healthcare: while 85% of cancer patients receive care in community settings, access to clinical trials has historically been concentrated in academic medical centers. The platform serves three key stakeholders: health systems and providers who can refer patients in under a minute without new systems or logins; biopharma sponsors who gain access to pre-qualified patients and faster enrollment; and payers and employers who can integrate clinical trial access into member benefits. Trial Library's technology includes Conversational AI Trial Search for natural language querying of protocols, Internal Referral Optimization that analyzes existing patient populations to match them to open trials, and an Intelligent Navigation OS that uses AI to proactively address barriers like transportation, food, language, and scheduling throughout the trial journey. The company operates one of the country's most dynamic research networks, spanning over 840 clinics and 3,000+ providers nationwide, partnering with leading health systems, pharma sponsors, and health plans to create a coordinated research ecosystem built around the patient.
Mission & Story
Mission
We are a team building the infrastructure that connects patients to what's possible. We unite health systems, biopharma, and payers into one coordinated research ecosystem, built around the patient.
Founding Story
Founded by physician-scientist Dr. Hala Borno, who witnessed first-hand the significant impact clinical trials have on improved healthcare outcomes and recognized the access gap between academic medical centers and community care settings where most patients receive treatment.
Clinical Focus
Medical conditions and clinical areas addressed by Trial Library.
Who It Serves
Milestones & Awards
Recent Milestones
Raised $10 million Series A funding in December 2025 co-led by SemperVirens Venture Capital and NEXT Ventures; launched Conversational AI Trial Search; expanded to 840+ clinics and 3,000+ providers; hired Chief Product Officer Karim Damji in September 2025
Key Partnerships
Social & Media
Latest Updates
May 20, 20264min readTrial Library today announced the launch of Conversational AI Trial Search, a new AI-native approach to identifying and navigating patients to clinical trials.by:Trial Library
2mo ago
.png)
December 2, 2025We're excited to share that Trial Library has raised $10 million in Series A funding, co-led by SemperVirens Venture Capital and NEXT Ventures.by:Trial Library
7mo ago
September 19, 2025With over two decades of experience driving growth and innovation in digital health and health tech, Karim brings a unique blend of strategic leadership, product insight, and startup success to our mission.by:Trial Library
10mo ago
.png)
September 16, 2025This Prostate Cancer Awareness Month, we're sharing John's story – a powerful reminder that the right support can make all the difference in a patient's clinical trial journey.by:Trial Library
10mo ago
.png)
September 16, 2025We’re thrilled to welcome James Jack to the Trial Library team as our new Head of BioPharma Partnerships.by:Trial Library
10mo ago
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.